Get the Stockscreener App
6.25
0.32%
-0.02
After Hours:
6.25
Kezar Life Sciences Inc stock is traded at $6.25, with a volume of 3,176.
It is down -0.32% in the last 24 hours and up +0.00% over the past month.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
See More
Previous Close:
$6.27
Open:
$6.27
24h Volume:
3,176
Relative Volume:
0.02
Market Cap:
$45.77M
Revenue:
$7.00M
Net Income/Loss:
$-70.79M
P/E Ratio:
-0.645
EPS:
-9.69
Net Cash Flow:
$-64.34M
1W Performance:
-0.16%
1M Performance:
+0.00%
6M Performance:
+36.46%
1Y Performance:
-6.02%
1-Day Range:
$6.235
$6.27
1-Week Range:
$6.23
$6.30
52-Week Range:
$3.5334
$6.93
Kezar Life Sciences Inc Stock (KZR) Company Profile
Name
Kezar Life Sciences Inc
Sector
Industry
Phone
650-822-5600
Address
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare KZR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KZR
Kezar Life Sciences Inc
|
6.25 | 45.92M | 7.00M | -70.79M | -64.34M | -9.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-17-25 | Downgrade | Jefferies | Buy → Hold |
| Oct-17-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-11-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-16-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-08-21 | Initiated | Wells Fargo | Overweight |
| Jul-16-18 | Initiated | Jefferies | Buy |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
| Jul-16-18 | Initiated | William Blair | Outperform |
View All
Kezar Life Sciences Inc Stock (KZR) Latest News
Financial Contrast: BioXcel Therapeutics (NASDAQ:BTAI) and Kezar Life Sciences (NASDAQ:KZR) - Defense World
Kezar Life Sciences (KZR) Upgraded to Buy: Here's What You Should Know - sharewise.com
Forecast Cut: Why Kezar Life Sciences Inc stock is seen as undervalued2025 Price Momentum & Daily Chart Pattern Signal Reports - moha.gov.vn
Kezar Life Sciences, Inc. (NASDAQ:KZR) Receives Average Recommendation of “Reduce” from Brokerages - Defense World
Kezar Life Sciences (NASDAQ:KZR) Shares Down 0.3% – Here’s Why - Defense World
Is Dhunseri Tea Industries Limiteds Business Expansion Justified by Stock ValuationInstitutional Buying Trends & Low Cost Portfolio Ideas - earlytimes.in
Return on assets % of Kezar Life Sciences Inc – GETTEX:2KZ0 - TradingView — Track All Markets
Why Kezar Life Sciences Inc. stock appeals to dividend seekersJuly 2025 Intraday Action & Technical Confirmation Trade Alerts - Улправда
Can Kezar Life Sciences Inc. stock deliver consistent earnings growthMarket Movement Recap & Free High Return Stock Watch Alerts - Улправда
How rising interest rates impact Kezar Life Sciences Inc. stockQuarterly Portfolio Review & Fast Gain Stock Trading Tips - Улправда
How Kezar Life Sciences Inc. stock benefits from tech adoptionGap Up & Verified Swing Trading Watchlist - Улправда
How Kezar Life Sciences Inc. (2KZ0) stock trades pre earningsAnalyst Downgrade & Community Consensus Trade Signals - DonanımHaber
How Kezar Life Sciences Inc. stock performs in rate cut cycles2025 Retail Activity & Long-Term Growth Portfolio Plans - Bölüm Sonu Canavarı
Will Kezar Life Sciences Inc. stock deliver better than expected guidanceQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - Улправда
Is Kezar Life Sciences Inc. (2KZ0) stock a good hedge against inflationStop Loss & Weekly Breakout Opportunity Watchlist - Улправда
Kezar Life Sciences Earnings Notes - Trefis
Layoff Tracker: Pfizer, Geron Downsize To Streamline Costs - BioSpace
Reviewing Dyadic International (NASDAQ:DYAI) and Kezar Life Sciences (NASDAQ:KZR) - Defense World
Can Kezar Life Sciences Inc. (2KZ0) stock beat analyst consensusJuly 2025 Rallies & Daily Chart Pattern Signals - Newser
How Kezar Life Sciences Inc. (2KZ0) stock compares with market leadersJuly 2025 Retail & Risk Controlled Stock Pick Alerts - Newser
Kezar Life Sciences (KZR) Stock Analysis Report | Financials & Insights - Benzinga
Will Kezar Life Sciences Inc. (2KZ0) stock sustain uptrend momentumMarket Movement Recap & Fast Entry Momentum Alerts - Newser
Kezar Life Sciences Reports Q3 2025 Financial Results - MSN
Kezar Life Sciences Inc. (KZR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How institutional buying supports Kezar Life Sciences Inc. stockJuly 2025 Volume & Fast Moving Market Watchlists - newser.com
How supply chain issues affect Kezar Life Sciences Inc. stockJuly 2025 Intraday Action & AI Powered Buy and Sell Recommendations - newser.com
What valuation multiples suggest for Kezar Life Sciences Inc. stockJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Top chart patterns to watch in Kezar Life Sciences Inc.Rate Cut & Fast Exit and Entry Trade Guides - newser.com
Is Kezar Life Sciences Inc. stock a safe haven assetSwing Trade & Reliable Volume Spike Trade Alerts - newser.com
Visual trend scoring systems applied to Kezar Life Sciences Inc.2025 Valuation Update & Weekly High Return Opportunities - newser.com
Is Kezar Life Sciences Inc. (2KZ0) stock a buy for dividend portfoliosMarket Weekly Review & Weekly High Conviction Ideas - newser.com
Is Kezar Life Sciences Inc. (2KZ0) stock ideal for retirement investorsTreasury Yields & Real-Time Chart Pattern Alerts - newser.com
How Kezar Life Sciences Inc. stock compares to industry benchmarksJuly 2025 Snapshot & Stock Portfolio Risk Control - newser.com
Will Kezar Life Sciences Inc. (2KZ0) stock attract long term capital inflows - newser.com
Will Kezar Life Sciences Inc. stock continue upward momentumWeekly Trade Summary & Low Drawdown Investment Strategies - newser.com
Kezar Life Sciences Initiates Major Overhaul Following Regulatory Setback - Ad-hoc-news.de
Equities Analysts Set Expectations for KZR FY2025 Earnings - Defense World
Kezar Life Sciences, Inc. (KZR) AI-Powered Stock Analysis - Meyka
Will Kezar Life Sciences Inc. stock beat EPS estimatesJuly 2025 Summary & Technical Pattern Based Buy Signals - newser.com
Kezar Life Sciences Inc Stock (KZR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Kezar Life Sciences Inc Stock (KZR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schiller Mark C. | Chief Operating Officer |
Jul 02 '25 |
Sale |
4.28 |
561 |
2,401 |
2,739 |
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):